Packaging Corporation of America vs BIO-TECHNE Corp — how do they compare? Packaging Corporation of America trades at $230.97 (market cap $20.49B), while BIO-TECHNE Corp trades at $72.44 (market cap $11.36B). The key difference: Packaging Corporation of America is the larger of the two by market cap, and Packaging Corporation of America pays the higher dividend (2.61%). Which is the better fit depends on your goals — on Pluang, investors hold Packaging Corporation of America for 45 Days and BIO-TECHNE Corp for 64 Days on average.
| PKG | TECH | |
|---|---|---|
Market Cap | $20.49B | $11.36B |
Volume | 493,499 | 5,390,331 |
Sector | Consumer Cyclical | Health |
52-Week High | $257.43 | $72.61 |
52-Week Low | $191.68 | $43.31 |
Typical Hold Time | 45 Days | 64 Days |
Enterprise Value | $24.30B | $11.39B |
Dividend Yield | 2.61% | 0.44% |
Signals from Pluang's Aura AI — not financial advice
Packaging Corporation of America (PKG) trades at $230.04, up 1.23% on the day, amid a bearish technical signal but with mixed fundamental performance. The stock shows a P/E of 29.86 and net income margin of 7.26%, with Q2 2026 earnings beating estimates. Recent news highlights institutional investments and a scheduled Q3 earnings call, while cash flow trends indicate increased capital expenditures.
PKG presents a cautious outlook with analyst consensus leaning Hold (57.69%) and a price target of $272.43 suggesting upside potential. Key risks include cost pressures and negative net cash flow, but strong corrugated demand and dividend payments offer stability. The stock's performance hinges on Q3 earnings results and margin management amid inflationary headwinds.
Bio-Techne (TECH) trades at $72.45, down 0.11% on the day, near its 52-week high of $72.70. The stock shows bullish technical signals with strong moving average support. Fundamentally, the company maintains solid gross margins of 65.77% but faces declining net income margins, dropping from 24.6% in 2022 to 6.01% in 2025. Recent shareholder approval of Merck KGaA's acquisition at $73 per share provides a clear near-term catalyst.
The pending acquisition offers limited upside from current levels but provides downside protection. However, declining profitability trends and elevated valuation ratios (P/E 62.46) pose risks if the deal falls through. Investors should weigh the acquisition premium against fundamental deterioration in earnings quality.
Trailing returns across standard periods
Latest headlines on both assets
Packaging Corporation of America is a leading producer of containerboard and corrugated packaging products in North America. The company also produces white papers, which include printing and writing papers. PKG operates as an integrated manufacturer, with a strong focus on high-quality and sustainable packaging solutions for e-commerce, food and beverage, and other industrial and consumer markets.
Read more on PKG →Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →